Rite Aid Corporation (RADCQ)
OTCMKTS: RADCQ · Delayed Price · USD
0.150
+0.020 (15.38%)
Jun 25, 2024, 3:44 PM EDT - Market closed

Rite Aid Revenue

Rite Aid had revenue of $23.73B in the twelve months ending June 3, 2023, down -2.83% year-over-year. Revenue in the quarter ending June 3, 2023 was $5.65B, a -6.01% decrease year-over-year. In the fiscal year ending March 4, 2023, Rite Aid had annual revenue of $24.09B, a decrease of -1.94%.

Revenue (ttm)
$23.73B
Revenue Growth
-2.83%
P/S Ratio
0.00
Revenue / Employee
$504,904
Employees
47,000
Market Cap
8.48M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 4, 202324.09B-476.36M-1.94%
Feb 26, 202224.57B525.02M2.18%
Feb 27, 202124.04B2.11B9.64%
Feb 29, 202021.93B288.84M1.33%
Mar 2, 201921.64B110.59M0.51%
Mar 3, 201821.53B-1.40B-6.10%
Mar 4, 201722.93B2.16B10.39%
Feb 27, 201620.77B-5.76B-21.71%
Feb 28, 201526.53B1.00B3.93%
Mar 1, 201425.53B134.15M0.53%
Mar 2, 201325.39B-728.96M-2.79%
Mar 3, 201226.12B906.32M3.59%
Feb 26, 201125.21B-454.21M-1.77%
Feb 27, 201025.67B-620.15M-2.36%
Feb 28, 200926.29B1.96B8.07%
Mar 1, 200824.33B6.93B39.81%
Mar 3, 200717.40B236.34M1.38%
Mar 4, 200617.16B346.61M2.06%
Feb 26, 200516.82B215.99M1.30%
Feb 28, 200416.60B809.17M5.12%
Mar 1, 200315.79B625.11M4.12%
Mar 2, 200215.17B649.31M4.47%
Mar 3, 200114.52B1.18B8.83%
Feb 26, 200013.34B900.51M7.24%
Feb 27, 199912.44B1.09B9.56%
Feb 28, 199811.35B4.38B62.87%
Mar 1, 19976.97B1.52B27.99%
Mar 2, 19965.45B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings